Takeda Pharmaceutical (TAK) Profit After Tax (2017 - 2025)
Historic Profit After Tax for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $673.9 million.
- Takeda Pharmaceutical's Profit After Tax fell 949.08% to $673.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.7 billion, marking a year-over-year increase of 4445.08%. This contributed to the annual value of $709.9 million for FY2025, which is 2899.72% down from last year.
- Per Takeda Pharmaceutical's latest filing, its Profit After Tax stood at $673.9 million for Q4 2025, which was down 949.08% from $4.7 billion recorded in Q3 2025.
- In the past 5 years, Takeda Pharmaceutical's Profit After Tax registered a high of $4.7 billion during Q3 2025, and its lowest value of -$20.2 million during Q1 2024.
- Moreover, its 5-year median value for Profit After Tax was $827.7 million (2022), whereas its average is $1.3 billion.
- As far as peak fluctuations go, Takeda Pharmaceutical's Profit After Tax crashed by 10254.51% in 2024, and later surged by 908369.57% in 2025.
- Over the past 5 years, Takeda Pharmaceutical's Profit After Tax (Quarter) stood at $508.7 million in 2021, then surged by 65.8% to $843.4 million in 2022, then increased by 27.7% to $1.1 billion in 2023, then plummeted by 30.86% to $744.6 million in 2024, then dropped by 9.49% to $673.9 million in 2025.
- Its Profit After Tax was $673.9 million in Q4 2025, compared to $4.7 billion in Q3 2025 and $1.5 billion in Q2 2025.